Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ARNALDO TORRES

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1437132263
CMS profile
291240
Location
ST PETERSBURG, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$8,052.99

257 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 6; records 51–100 of 257 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ARNALDO TORRES

NPI 1437132263 · CMS profile ID 291240

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

ST PETERSBURG, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 6; records 51–100 of 257 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1437132263?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ARNALDO TORRES, NPI 1437132263, CMS profile ID 291240. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 6; records 51–100 of 257 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1437132263?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). ARNALDO TORRES, NPI 1437132263, CMS profile ID 291240. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 6; records 51–100 of 257 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1437132263?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
ARNALDO TORRES, NPI 1437132263, CMS profile ID 291240, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 6; records 51–100 of 257 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1437132263?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

257 matching records · $8,052.99 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 257 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 257.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $7.9610/24/2024 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1155805276 CMS
Janssen Biotech, Inc. $5.2110/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078515525 CMS
Janssen Biotech, Inc. $5.0710/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078515556 CMS
GlaxoSmithKline, LLC. $32.2810/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116510421 CMS
PFIZER INC. $23.1410/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132125165 CMS
UCB, Inc. $22.6110/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143040403 CMS
Amgen Inc. $14.5810/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111726437 CMS
Amgen Inc. $18.1410/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111726405 CMS
ABBVIE INC. $20.5910/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106234184 CMS
ABBVIE INC. $79.0210/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106234182 CMS
AstraZeneca Pharmaceuticals LP $25.1010/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105878265 CMS
Janssen Biotech, Inc. $29.5010/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078515117 CMS
UCB, Inc. $27.4710/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143040401 CMS
Amgen Inc. $19.5710/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117400456 CMS
PFIZER INC. $10.3310/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132079759 CMS
Lilly USA, LLC $9.4510/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136000673 CMS
Radius Health, Inc. $23.2810/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089936332 CMS
Janssen Biotech, Inc. $30.0510/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078516256 CMS
Amgen Inc. $15.3510/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111726435 CMS
Amgen Inc. $22.0209/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111726403 CMS
Novartis Pharmaceuticals Corporation $24.7409/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087416870 CMS
E.R. Squibb & Sons, L.L.C. $24.7409/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101797425 CMS
GlaxoSmithKline, LLC. $32.2809/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116604932 CMS
Amgen Inc. $19.5709/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117400454 CMS
AstraZeneca Pharmaceuticals LP $26.8909/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105676317 CMS
Lilly USA, LLC $8.4409/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136051953 CMS
PFIZER INC. $22.3109/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131952340 CMS
UCB, Inc. $29.1509/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143040399 CMS
ABBVIE INC. $25.1109/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106234180 CMS
Janssen Biotech, Inc. $7.1409/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078515570 CMS
Janssen Biotech, Inc. $0.6509/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078516113 CMS
Janssen Biotech, Inc. $2.3309/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078516200 CMS
Novartis Pharmaceuticals Corporation $28.4209/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087416866 CMS
Novartis Pharmaceuticals Corporation $0.7309/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087416868 CMS
Amgen Inc. $30.1809/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111726469 CMS
ABBVIE INC. $27.0709/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106234178 CMS
Amgen Inc. $11.1509/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111726463 CMS
Janssen Biotech, Inc. $1.1509/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078514882 CMS
Janssen Biotech, Inc. $6.6309/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078515745 CMS
Janssen Biotech, Inc. $3.4309/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078516677 CMS
PFIZER INC. $4.3108/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131926286 CMS
Sandoz Inc. $15.9808/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089364389 CMS
Amgen Inc. $10.8308/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111726461 CMS
AstraZeneca Pharmaceuticals LP $114.3008/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105695720 CMS
Amgen Inc. $9.4808/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111726433 CMS
Janssen Biotech, Inc. $26.1108/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078515313 CMS
Novartis Pharmaceuticals Corporation $25.2508/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087416864 CMS
UCB, Inc. $0.0408/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143040393 CMS
UCB, Inc. $0.5208/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143040395 CMS
UCB, Inc. $14.6508/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143040397 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $17,564.63 196
PY2020 $11,269.01 148
PY2021 $5,866.49 212
PY2022 $12,211.12 211
PY2023 $13,073.36 224
PY2024 $8,052.99 257
PY2025 $21,342.30 249

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $57,202.00 11
PY2024 Principal investigator $35,197.00 6
PY2023 Recipient $1,294.65 9
PY2023 Principal investigator $35,269.84 7
PY2022 Principal investigator $18,825.78 5
PY2021 Principal investigator $39,791.88 5
PY2019 Recipient $1,558.83 14
PY2019 Principal investigator $9,886.00 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $2,500.00 12/23/2025 Non-covered Recipient Entity
BAYCARE HEALTH SYSTEM INC
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus (SELECT-SLE) No dispute reported 06/30/2026 1202531774
Principal investigator 1 ABBVIE INC. $1,485.00 11/04/2025 Non-covered Recipient Entity
BAYCARE HEALTH SYSTEM INC
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH) No dispute reported 06/30/2026 1202520181
Principal investigator 1 ABBVIE INC. $4,250.00 10/28/2025 Non-covered Recipient Entity
BAYCARE HEALTH SYSTEM INC
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH) No dispute reported 06/30/2026 1202518723
Principal investigator 1 ABBVIE INC. $19,440.00 10/28/2025 Non-covered Recipient Entity
BAYCARE HEALTH SYSTEM INC
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH) No dispute reported 06/30/2026 1202518725
Principal investigator 1 ABBVIE INC. $600.00 10/22/2025 Non-covered Recipient Entity
BAYCARE HEALTH SYSTEM INC
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus (SELECT-SLE) No dispute reported 06/30/2026 1202518061
Principal investigator 1 ABBVIE INC. $2,025.00 09/30/2025 Non-covered Recipient Entity
BAYCARE HEALTH SYSTEM INC
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH) No dispute reported 06/30/2026 1202512818
Principal investigator 1 ABBVIE INC. $3,942.00 09/30/2025 Non-covered Recipient Entity
BAYCARE HEALTH SYSTEM INC
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus (SELECT-SLE) No dispute reported 06/30/2026 1202512820
Principal investigator 1 ABBVIE INC. $600.00 08/28/2025 Non-covered Recipient Entity
BAYCARE HEALTH SYSTEM INC
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH) No dispute reported 06/30/2026 1202506481
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $4,060.00 06/13/2025 Non-covered Recipient Entity
BAYCARE HEALTH SYSTEMS INC
A Multi-Center, Randomized, Double-Blind, and Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects with Active Psoriatic Arthritis Stratified by Prior Biologic Use (LATITUDE-PsA-3002 No dispute reported 06/30/2026 1223281272
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $15,000.00 06/04/2025 Non-covered Recipient Entity
BAYCARE HEALTH SYSTEMS INC
A Multi-Center, Randomized, Double-Blind, and Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects with Active Psoriatic Arthritis Stratified by Prior Biologic Use (LATITUDE-PsA-3002 No dispute reported 06/30/2026 1223280680
Principal investigator 1 AstraZeneca UK Limited $3,300.00 03/19/2025 Non-covered Recipient Entity
BAYCARE HEALTH SYSTEM
A Multicenter Randomized Double-blind Placebo-controlled Phase 3 Study Evaluating the Efficacy and Safety of Subcutaneous Anifrolumab in Adult Patients with Systemic Lupus Erythematosus No dispute reported 06/30/2026 1185540938